Rifkin, R M <br/><br/>
A phase I study of therapy with recombinant granulocyte-macrophage colony-stimulating factor administered by IV bolus or continuous infusion.  [electronic resource] 

 -  Behring Institute Mitteilungen  Aug 1988 
 - 125-33 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0301-0457 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acquired Immunodeficiency Syndrome--drug therapy<br/>Anemia, Aplastic--drug therapy<br/>Bone Marrow--pathology<br/>Colony-Stimulating Factors--administration & dosage<br/>Drug Evaluation<br/>Felty Syndrome--drug therapy<br/>Female<br/>Granulocyte-Macrophage Colony-Stimulating Factor<br/>Growth Substances--administration & dosage<br/>Humans<br/>Infusions, Intravenous<br/>Injections, Intravenous<br/>Male<br/>Middle Aged<br/>Neoplasms--drug therapy<br/>Recombinant Proteins--administration & dosage